These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26303611)

  • 1. Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels.
    Sá MJ; Rocha JC; Almeida MF; Carmona C; Martins E; Miranda V; Coutinho M; Ferreira R; Pacheco S; Laranjeira F; Ribeiro I; Fortuna AM; Lacerda L
    JIMD Rep; 2016; 26():53-60. PubMed ID: 26303611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
    Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
    J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
    Molzer B; Stöckler S; Bernheimer H
    Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder.
    Demaret T; Roumain M; Ambroise J; Evraerts J; Ravau J; Bouzin C; Bearzatto B; Gala JL; Stepman H; Marie S; Vincent MF; Muccioli GG; Najimi M; Sokal EM
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165900. PubMed ID: 32693164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
    Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
    Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audiological findings in Infantile Refsum disease.
    Vandana VP; Bindu PS; Nagappa M; Sinha S; Taly AB
    Int J Pediatr Otorhinolaryngol; 2015 Aug; 79(8):1366-9. PubMed ID: 26055198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the degradation of [U-3H]-phytanic acid and [U-3H]-pristanic acid in cultured fibroblasts from children with peroxisomal disorders.
    Kase BF; Björkhem I
    Scand J Clin Lab Invest; 1996 May; 56(3):211-7. PubMed ID: 8761525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
    Kruska N; Reiser G
    Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children.
    Budden SS; Kennaway NG; Buist NR; Poulos A; Weleber RG
    J Pediatr; 1986 Jan; 108(1):33-9. PubMed ID: 2418187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction.
    Poll-The BT; Saudubray JM; Ogier H; Schutgens RB; Wanders RJ; Schrakamp G; van den Bosch H; Trijbels JM; Poulos A; Moser HW
    J Inherit Metab Dis; 1986; 9(2):169-74. PubMed ID: 2427795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.
    Lipiński P; Stawiński P; Rydzanicz M; Wypchło M; Płoski R; Stradomska TJ; Jurkiewicz E; Ferdinandusse S; Wanders RJA; Vaz FM; Tylki-Szymańska A
    J Appl Genet; 2020 Feb; 61(1):87-91. PubMed ID: 31628608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It's Never Too Late for a Diagnosis.
    Coelho M; Durães J; Freixo J; Tomás J; Macário C
    Endocr Metab Immune Disord Drug Targets; 2023 Oct; ():. PubMed ID: 37859411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers predicting survival in peroxisome biogenesis disorders.
    Gootjes J; Mooijer PA; Dekker C; Barth PG; Poll-The BT; Waterham HR; Wanders RJ
    Neurology; 2002 Dec; 59(11):1746-9. PubMed ID: 12473763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopic liver transplantation from a living-related donor in an infant with a peroxisome biogenesis defect of the infantile Refsum disease type.
    Van Maldergem L; Moser AB; Vincent MF; Roland D; Reding R; Otte JB; Wanders RJ; Sokal E
    J Inherit Metab Dis; 2005; 28(4):593-600. PubMed ID: 15902563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids.
    Christensen E; Pedersen SA; Leth H; Jakobs C; Schutgens RB; Wanders RJ
    J Inherit Metab Dis; 1997 Sep; 20(5):658-64. PubMed ID: 9323560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of phytanic acid and pristanic acid in man: a review.
    Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
    J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
    Poulos A; Sharp P; Fellenberg AJ; Johnson DW
    Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
    Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
    Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Lipotoxicity of Phytanic Acid and Very Long-chain Fatty Acids. Harmful Cellular/Mitochondrial Activities in Refsum Disease and X-Linked Adrenoleukodystrophy.
    Schönfeld P; Reiser G
    Aging Dis; 2016 Mar; 7(2):136-49. PubMed ID: 27114847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
    Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
    Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.